1-7 of 7
Nikki Ann Evensen
Close
Sort by
Journal Articles

The Role of Relapse Specific over-Expression of S100A8/A9 B Leukemic Cells in Promoting Chemoresistance

Clemence Aldebert, Emily Duan, Sylwia Jasinski, Talia H Ostrow, Isaiah Gonzalez, Aristotelis Tsirigos, Elizabeth A. Raetz, Nikki Ann Evensen, William L. Carroll
Journal: Blood
Blood (2022) 140 (Supplement 1): 6337–6338.
https://doi.org/10.1182/blood-2022-169273
Published: 2022
Journal Articles

Non-Classical Monocyte Abundance Is an Independent Adverse Risk Factor for Relapse in Pediatric B-ALL

Gloria Paz Contreras Yametti, Nikki Ann Evensen, Meenakshi Devidas, Elizabeth A. Raetz, Karen R Rabin, David T. Teachey, Iannis Aifantis, William L. Carroll, Matthew Witkowski
Journal: Blood
Blood (2021) 138 (Supplement 1): 1316.
https://doi.org/10.1182/blood-2021-146918
Published: 2021
Journal Articles

The NSD2 p.E1099K Mutation in Relapse Pediatric Acute Lymphoblastic Leukemia Is Linked to Mercaptopurine Resistance

Jason Saliba, PhD, Joanna Pierro, DO, Nikki Ann Evensen, PhD BS, Anita Qualls, Natasha Belsky, William L. Carroll, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3962.
https://doi.org/10.1182/blood-2018-99-117799
Published: 2018
Journal Articles

NSD2 Mutations in Pediatric ALL Leads to a Distinct Gene Expression Profile and Epigenetic Landscape That Is Cell Context Specific

Joanna Pierro, DO, Jason Saliba, PhD, Nikki Ann Evensen, PhD BS, William L. Carroll, MD, Gunjan Sethia, MS, Shella Saint Fleur-Lominy, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3905.
https://doi.org/10.1182/blood-2018-99-118535
Published: 2018
Journal Articles

The Role of MMSET E1099K Mutation in Gene Dysregulation, Drug Resistance and Clonogenicity in Acute B-Lymphoblastic Leukemia

Joanna Pierro, DO, Jason Saliba, PhD, Nikki Ann Evensen, PhD BS, Yixiao Gong, Shella Saint Fleur-Lominy, MDPhD, William L. Carroll, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2474.
https://doi.org/10.1182/blood.V130.Suppl_1.2474.2474
Published: 2017
Journal Articles

Using Whole Exome Sequencing in Pediatric Acute Lymphoblastic Leukemia Germline, Diagnosis, and Relapse Trios to Discover Novel Relapse Enriched Mutations for Clonal Backtracking By Ddpcr

Jason Saliba, PhD, Nikki Ann Evensen, PhD BS, Julia Meyer, PhD, Igor Dolgalev, MS, Daniel Newman, BA, BSc, Ashfiyah Chowdhury, BSc, Jacob Nersting, PhD, Jinhua Wang, PhD, Kjeld Schmiegelow, MD DMSc, William L. Carroll, MD
Journal: Blood
Blood (2016) 128 (22): 4085.
https://doi.org/10.1182/blood.V128.22.4085.4085
Published: 2016
Journal Articles

Measurement of Phosphorylated ERK As a Prognostic and Predictive Marker for MEK Inhibition in Pediatric B-Lymphoblastic Leukemia: A Pilot Study

Pillai Pallavi Madhusoodhan, MD, Nikki Ann Evensen, PhD BS, Jason Saliba, PhD, Ashfiyah Chowdhury, BS, Daniel Newman, BA, BS, Cristina Delgado-Martin, PhD, Teena Bhatla, MD, Mignon L. Loh, MD, Michelle L. Hermiston, MD PhD, William L. Carroll, MD
Journal: Blood
Blood (2016) 128 (22): 1739.
https://doi.org/10.1182/blood.V128.22.1739.1739
Published: 2016